Against the odds, GSK has secured FDA approval for its multiple myeloma therapy Blenrep, three years after it was removed ...

The Nubeqa (darolutamide) regimen can be used to treat adult patients with advanced HSPC if docetaxel, a chemotherapy agent, ...

GSK and Spero Therapeutics' oral cabapenem, tebipenem HBr, has become the first antibiotic in the class to show efficacy in a ...

As someone with a sound scientific background, immersed in the technical side of this work, I’ve seen firsthand how the field ...

AstraZeneca has breached the UK pharma industry's code of practice with a claim on its website for asthma drug Symbicort, ...

Patient safety is a mindset that begins on day one and grows with every child. It is not confined to hospitals, it extends ...

A new report from the Institute for Clinical and Economic Review (ICER) in the US has found that the net prices of newly ...

Merck KGaA has become the third pharma company to reach an agreement with the Trump administration to cut the cost of some of ...

Johnny Cheng, currently CFO of HUTCHMED, has been named acting CEO following the departure of Dr Weiguo Su due to health ...

The immediate consequences of the disappointing result are a big reduction in workforce at South San Francisco-based Alector, ...

The FDA has named the first products to take advantage of its recently announced Commissioner's national priority voucher ...

Insmed's DPP1 inhibitor Brinsupri (brensocatib) has been recommended by the CHMP for the treatment of patients aged 12 and ...